1.
Al-Hasso IKQ. Evaluation of Interleukin-22 and Toll-like receptor-2 as an Immunological Biomarkers in Breast Cancer Patients. Al-Kindy Col. Med. J [Internet]. 2024 Aug. 1 [cited 2024 Dec. 19];20(2):97-100. Available from: https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/1263